This study looked at spectral analysis of heart rate variability (HRV) between patients with type 2 diabetes mellitus (DM) and healthy controls. The association between diabetic autonomic neuropathy (DAN) with HRV parameter changes and DM risk factors (including nephropathy) was investigated. HRV parameters were compared between 271 patients with DM and 160 controls. A statistically significant difference was found between the two groups for each parameter. Patients with DM were then divided into three groups by the levels of individual risk factors: body mass index, total cholesterol, 2-h postprandial plasma glucose concentration, glycosylated haemoglobin, duration of DM and the albumin—creatinine ratio. HRV parameters decreased significantly in patients with DM as the risk factor level progressed. This study identified previously known and new potential risk factors for the development of DAN, which may be important for the development of risk reduction strategies.
AkselrodSGordonDUbelFA: Power spectrum analysis of heart rate fluctuation: A quantitative probe of beat-to-beat cardiovascular control. Science1981; 213: 220–222.
2.
VithianKHurelS: Microvascular complications: pathophysiology and management. Clin Med2010; 10: 505–509.
3.
PutzZKemplerPJermendyG: Diabetes-specific complications in prediabetes. Orv Hetil2009; 150: 2139–2145 [in Hungarian, English abstract].
4.
AyadFBelhadjMPariésJ: Association between cardiac autonomic neuropathy and hypertension and its influence on diabetic complications. Diabet Med2010; 27: 804–811.
5.
BaselliGCeruttiSCivardiS: Heart rate variability signal processing: A quantitative approach as an aid to diagnosis in cardiovascular pathologies. Int J Biomed Comput1987; 20: 51–70.
6.
MoonSSChoiYKSeoHA: Relationship between cardiovascular autonomic neuropathy and coronary artery calcification in patients with type 2 diabetes. Endocr J2010; 57: 445–454.
MaserRELenhardMJ: Cardiovascular autonomic neuropathy due to diabetes mellitus: clinical manifestations, consequences, and treatment. J Clin Endocrinol Metab2005; 90: 5896–5903.
9.
BoultonAJVinikAIArezzoJC: Diabetic neuropathies: A statement by the American Diabetes Association. Diabetes Care2005; 28: 956–962.
10.
ZieglerDDannehlKVolkswD: Prevalence of cardiovascular autonomic nerve dysfunction assessed by spectral analysis and standard tests of heart rate variation in newly diagnosed IDDM patients. Diabetes Care1992; 15: 908–911.
11.
ValensiPHuardJPGirouxC: Factors involved in cardiac autonomic neuropathy in diabetic patients. J Diabetes Complications1997; 11: 180–187.
12.
YoungRJMacintyreCCMartynCN: Progression of subclinical polyneuropathy in young patients with type 1 (insulin-dependent) diabetes: associations with glycaemic control and microangiopathy (microvascular complications). Diabetologia1986; 26: 156–161.
13.
RatzmannKPRaschkeMGanderI: Prevalence of peripheral and autonomic neuropathy in newly diagnosed type II (noninsulin dependent) diabetes. J Diabetes Complications1991; 5: 1–5.
14.
ValensiPPariesJAttaliJR: Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity and microangiopathic complications. The French multicenter study. Metabolism2003; 52: 815–820.
15.
Pop-BusuiREvansGWGersteinHC: Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care2010; 33: 1578–1584.
16.
SpalloneVMaielloMRCicconettiE: Autonomic neuropathy and cardiovascular risk factors in insulin-dependent and non insulin-dependent diabetes. Diabetes Res Clin Pract1997; 34: 169–179.
17.
OsterhuesHHGrossmannGKochsM: Heart-rate variability for discrimination of different types of neuropathy in patients with insulin-dependent diabetes mellitus. J Endocrinol Invest1998; 21: 24–30.
18.
BernardiLRicordiLLazzariP: Impaired circadian modulation of sympathovagal activity in diabetes. A possible explanation for altered temporal onset of cardiovascular disease. Circulation1992; 86: 1443–1452.
19.
SpalloneVBernardiLRicordiL: Relationship between the circadian rhythms of blood pressure and sympathovagal balance in diabetic autonomic neuropathy. Diabetes1993; 42: 1745–1752.
20.
VibertiGCJarrettRJMahmudU: Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet1982; 319: 1430–1432.
21.
ForsblomCMGroopPHEkstrandA: Predictive value of microalbuminuria in patients with insulin-dependent diabetes of long duration. BMJ1992; 305: 1051–1053.
22.
ShieldJPHHuntLPKarachaliouF: Is microalbuminuria progressive?Arch Dis Child1995; 73: 512–514.
23.
ComiGPescatoriDBossiA: Clinical and instrumental diagnosis of autonomic neuropathy in insulin dependent diabetics. Acta Diabetol Lat1982; 19: 377–384.
24.
PaganiMLombardiFGuzzettiS: Power spectral analysis of heart rate and arterial blood pressure variabilities as a marker of sympathovagal interaction in man and conscious dog. Circ Res1986; 59: 178–193.
25.
YamasakiYUedaNKishimotoM: Assessment of early stage autonomic nerve dysfunction in diabetic subjects—application of power spectral analysis of heart rate variability. Diabetes Res1991; 17: 73–80.
26.
PomeranzBMacaulayRJCaudillMA: Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol1985; 248: H151–H153.
27.
SpalloneVGambardellaSMaielloMR: Relationship between autonomic neuropathy, 24 hour blood pressure profile, and nephropathy in normotensive IDDM patients. Diabetes Care1994; 17: 578–584.
28.
MørkridKAliLHussainA: Risk factors and prevalence of diabetic peripheral neuropathy: A study of type 2 diabetic outpatients in Bangladesh. Int J Diabetes Dev Ctries2010; 30: 11–17.
